In vitro generation of novel pyrimethamine resistance mutations in the Toxoplasma gondii dihydrofolate reductase
about
Characterisation and expression of a PP1 serine/threonine protein phosphatase (PfPP1) from the malaria parasite, Plasmodium falciparum: demonstration of its essential role using RNA interferenceTargeting purine and pyrimidine metabolism in human apicomplexan parasitesGrowth-inhibitory effects of artesunate, pyrimethamine, and pamaquine against Babesia equi and Babesia caballi in in vitro cultures.Antimicrobial dihydrofolate reductase inhibitors--achievements and future options: review.Genetic Polymorphisms and Phenotypic Profiles of Sulfadiazine-Resistant and Sensitive Toxoplasma gondii Isolates Obtained from Newborns with Congenital Toxoplasmosis in Minas Gerais, Brazil.Characterization of aspartyl aminopeptidase from Toxoplasma gondii.Drugs in development for toxoplasmosis: advances, challenges, and current status.The efficacy of herbal medicines against Toxoplasma gondii during the last 3 decades: a systematic review.Effects of extracts from Echinacea purpurea (L) MOENCH on mice infected with different strains of Toxoplasma gondii.Lausannevirus Encodes a Functional Dihydrofolate Reductase Susceptible to Proguanil.In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone.Characterization of Plasmodium Atg3-Atg8 interaction inhibitors identifies novel alternative mechanisms of action in Toxoplasma gondii.Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box.Homology modeling of dihydrofolate reductase from T. gondii bonded to antagonists: molecular docking and molecular dynamics simulations.Drug Resistance in
P2860
Q24791686-AD02BECF-7583-4288-842C-4CEC8ED0C740Q28629739-E74B1F10-50EA-4D0F-95A5-D2054B442F92Q34820970-D814B503-1EF3-4F50-808C-E92A5E25BA65Q35743445-A55BC86D-F52D-490B-B8CF-9A8447727ADFQ36258864-7E983E5E-9D78-4407-BB15-DFB6AA3B7490Q37291149-8E37A305-C75D-4017-83F1-5A8C9450BD5CQ37613765-8C412197-31A8-4F69-8F5E-534333CE5FB8Q38937807-305A3622-EC6E-4E8B-8A82-7D0154E6A79DQ39699655-6A24EF85-34B7-4795-BE95-C79BF45E5384Q40358605-053E72B4-44C1-4B03-BB78-EDC5D40E0D16Q41831157-F9072F86-226E-45C9-B457-F2F320F70077Q47381598-D84896B6-812F-44B3-A542-B9D63250ED97Q48016385-AC2B2AEF-0FC9-4FF1-9E0A-DDC90A7F8DE6Q48034666-E65DE8C5-FEC9-45DA-A030-5F89DD3E8BFFQ58699076-A205F711-72B4-4A0A-92C7-876E1D4F9BEE
P2860
In vitro generation of novel pyrimethamine resistance mutations in the Toxoplasma gondii dihydrofolate reductase
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
In vitro generation of novel p ...... gondii dihydrofolate reductase
@ast
In vitro generation of novel p ...... gondii dihydrofolate reductase
@en
type
label
In vitro generation of novel p ...... gondii dihydrofolate reductase
@ast
In vitro generation of novel p ...... gondii dihydrofolate reductase
@en
prefLabel
In vitro generation of novel p ...... gondii dihydrofolate reductase
@ast
In vitro generation of novel p ...... gondii dihydrofolate reductase
@en
P2860
P1476
In vitro generation of novel p ...... gondii dihydrofolate reductase
@en
P2093
P2860
P304
P356
10.1128/AAC.45.4.1271-1277.2001
P407
P50
P577
2001-04-01T00:00:00Z